Find out what’s new and what’s next in treatment options for TK2d.
-
-
Study clarifies how late-onset TK2 deficiency progresses over time
-
Genetic reanalysis links MGME1 variant to TK2-related mitochondrial disease
-
Thrown into rare, and finding the puzzle pieces fit
-
Tk2 loss drives mitochondrial failure in frequent epilepsy seizures
-
Clinical trial in Spain to evaluate doxecitin and doxribtimine in TK2d
-
The benefits of keeping a symptom log if you have TK2d